These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12712021)

  • 1. Visualization of myocardial perfusion after percutaneous myocardial septal ablation for hypertrophic cardiomyopathy using superharmonic imaging.
    Ten Cate FJ; Bouakaz A; Krenning B; Vletter W; de Jong N
    J Am Soc Echocardiogr; 2003 Apr; 16(4):370-2. PubMed ID: 12712021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast superharmonic imaging: a feasibility study.
    Bouakaz A; Krenning BJ; Vletter WB; ten Cate FJ; De Jong N
    Ultrasound Med Biol; 2003 Apr; 29(4):547-53. PubMed ID: 12749924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.
    Pedone C; Biagini E; Galema TW; Vletter WB; ten Cate FJ
    J Am Soc Echocardiogr; 2006 Aug; 19(8):982-6. PubMed ID: 16880092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Jaber WA; Yang EH; Nishimura RA; Sorajja P; Rihal CS; Elesber A; Eeckhout E; Lerman A
    Heart; 2009 Apr; 95(7):564-9. PubMed ID: 18952634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring.
    Faber L; Ziemssen P; Seggewiss H
    J Am Soc Echocardiogr; 2000 Dec; 13(12):1074-9. PubMed ID: 11119274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of selective myocardial contrast echocardiography in percutaneous transluminal septal myocardial ablation: a case report.
    Okayama H; Sumimoto T; Morioka N; Yamamoto K; Kawada H
    Jpn Circ J; 2001 Sep; 65(9):842-4. PubMed ID: 11548888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area.
    Faber L; Seggewiss H; Ziemssen P; Gleichmann U
    Catheter Cardiovasc Interv; 1999 Aug; 47(4):462-6. PubMed ID: 10470478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy.
    Pedone C; Vijayakumar M; Ligthart JM; Valgimigli M; Biagini E; De Jong N; Serruys PW; Ten Cate FJ
    Int J Cardiovasc Intervent; 2005; 7(3):134-7. PubMed ID: 16243734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiography-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Hsieh TC; Patel K
    Anesth Analg; 2011 Jul; 113(1):44-6. PubMed ID: 21519056
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal branch selection in alcohol septal ablation.
    Toutouzas K; Karanasos A; Anastasakis A; Vavuranakis M; Seggewiss H; Stefanadis C; Rigopoulos A
    Int J Cardiol; 2011 Feb; 147(1):143-4. PubMed ID: 19910065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of subtle myocardial noncompaction by contrast echocardiography in patients with hypertrophic cardiomyopathy and its relationship with regional ventricular systolic dysfunction.
    Wang C; Deng YB; Zhu Y; Liu YN; Bi XJ
    J Ultrasound Med; 2012 Oct; 31(10):1551-7. PubMed ID: 23011618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial scarring by contrast enhanced magnetic resonance imaging in a patient 11 years after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Butz T; Horstkotte D; Koerfer J; Langer C; Seggewiss H; Faber L
    Int J Cardiol; 2010 Nov; 145(1):e3-5. PubMed ID: 19171399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of successful and failed alcohol septal ablations for obstructive hypertrophic cardiomyopathy.
    Mayer SA; Anwar A; Grayburn PA
    Am J Cardiol; 2003 Jul; 92(2):241-2. PubMed ID: 12860237
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracoronary myocardial contrast echocardiography in a patient with drug refractory hypertrophic obstructive cardiomyopathy revealing extensive myocardium at risk for infarction with alcohol septal ablation.
    Monakier D; Horlick E; Ross J; Woo A; Rakowski H; Schwartz L; Riley MP; Carver JR; Aggarwal K; James EA; Aziz S; Ramsdale DR
    J Invasive Cardiol; 2004 Sep; 16(9):482-4. PubMed ID: 15353829
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative analysis of intraprocedural myocardial contrast echocardiography during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy.
    Hering D; Welge D; Fassbender D; Horstkotte D; Faber L
    Eur J Echocardiogr; 2004 Dec; 5(6):443-8. PubMed ID: 15556820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy.
    Monakier D; Woo A; Puri T; Schwartz L; Ross J; Jamorski M; Yang H; Liu Z; Vannan M; Wigle ED; Rakowski H
    Am J Cardiol; 2004 Dec; 94(12):1515-22. PubMed ID: 15589007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent].
    Pfeiffer B; Rigopoulos A; Seggewiß H
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2093-6. PubMed ID: 23033167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report].
    Sakakibara M; Abe S; Fusegawa Y; Nakajima T; Iwata O; Goto S; Shiina Y; Handa S
    J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M; Dokainish H; Lakkis N
    J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparable effects of percutaneous transluminal septal myocardial ablation and subaortic ventriculotomy in treating patients with hypertrophic obstructive cardiomyopathy, an echocardiography follow-up study].
    Li J; Liu YL; He Q; Qiao SB; Feng W; Lü XZ; Zhu ZH; Ling Y; Wang JP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):695-8. PubMed ID: 17081391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.